News | Oncology Diagnostics | May 25, 2016

New Photonics Device to Transform Diagnosis of Skin Cancer

Optoacoustic technology combines light and ultrasound waves to get high-quality, non-invasive image without biopsies

May 25, 2016 — Scientists are developing a new photonics device that listens to light and could be capable of detecting skin cancer and other diseases more accurately than ever before, eliminating the need for unnecessary and invasive biopsies.

With around 232,000 people around the world estimated to have been diagnosed with malignant melanoma in 2012, and with 55,500 deaths, early diagnosis of the disease could see hundreds of thousands of lives saved over the next ten years, improve quality of life and reduce healthcare costs.    

Traditionally, skin diseases are diagnosed visually by a physician using the naked eye or a magnifying glass and personal experience to make a decision. Invasive, uncomfortable and potentially damaging procedures such as biopsies are often performed to confirm or exclude the presence of disease. This new breakthrough, dubbed INNODERM (Innovative Dermatology Healthcare based on Label-Free Spectral Optoacuostic Mesoscopy) would give physicians an accurate and reliable way to objectively identify serious skin diseases for the first time.

“We are essentially listening to light, allowing us to see not just structures but molecules and biology on and under the skin, at depths and contrast never visualized before. It will enable physicians to make accurate and objective diagnosis of skin conditions for the first time,” said Prof. Vasilis Ntziachristos, INNODERM coordinator and chair for biological imaging at the Technical University of Munich.

The method uses opto-acoustics, sending light waves of different wavelengths into the skin and detecting ultrasound waves generated within tissue in response to light absorption to build up an image of the skin tissue and specific molecules therein.

The prototype can visualize at depths up to 5mm under the skin, measures 4cm x 4cm x 7cm — no bigger than a small apple — and can be placed on the skin to generate a high-resolution image in less than a minute. Being portable and of small form factor means that it could be used on expeditions or in remote areas of the world where a young doctor with little experience can make accurate, objective diagnoses.  

“The device allows us to see blood vessels, skin oxygenation and potentially several novel pathophysiological features which are an integral area in the development of diseases. No one has ever been able to see like this before,” continued Ntziachristos.

INNODERM combines the expertise of world-class engineers, scientists and clinicians in a consortium comprising five partners from four European countries.

The project has been awarded a grant of €3.8 million from Horizon 2020, the European Union (EU) framework program for research and innovation under the Photonics21 Public Private Partnership.

For more information: www.ec.europa.eu/programmes/horizon2020

Related Content

Charles Ananian, M.D.

Charles Ananian, M.D.

Sponsored Content | Case Study | Digital Radiography (DR) | November 07, 2018
Whether it’s a premature baby or a critically ill child, treating little patients is a huge responsibility.
Results of the vertebrae-based analysis (383 vertebrae in 34 patients) for detection of BME.

Results of the vertebrae-based analysis (383 vertebrae in 34 patients) for detection of BME.

Sponsored Content | Case Study | Computed Tomography (CT) | November 06, 2018
The following is a summary of a study published in the
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
Biomarker blood test accurately confirms remission in non-smoker with HPV-associated oral cancer. ASTRO 2018 #ASTRO2018 #ASTRO #ASTRO18

Biomarker blood test accurately confirms remission in non-smoker with HPV-associated oral cancer.

News | Radiation Oncology | October 30, 2018
October 30, 2018 — A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to
Huntsman Cancer Institute Installs First Preclinical nanoScan 3T PET/MRI in U.S.
News | PET-MRI | October 10, 2018
The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of Utah in Salt Lake...
X-ray Mammography Adoption to Skyrocket for Breast Cancer Detection
News | Mammography | October 08, 2018
Highly populated countries have traditionally been slow adopters of non-conventional business models, but a new Frost...
Body Vision Medical Announces Release of LungVision
Technology | Lung Cancer | October 05, 2018
Body Vision Medical, a medical device company specializing in lung cancer diagnostics, announced the launch of its...
An example of the newest generation of smart cardiac CT software that automatically identifies the anatomy, autotraces the centerlines on the entire coronary tree and labels each vessel segment.

An example of the newest generation of smart cardiac CT software that automatically identifies the anatomy, autotraces the centerlines on the entire coronary tree and labels each vessel segment. This greatly speeds CT workflows, saving time for techs, radiologists and cardiologists.

Feature | Radiology Imaging | October 04, 2018 | By Dave Fornell
Here is a checklist of dose-sparing practices for cardiac computed tomography (CT) imaging used in the cath lab.
Leica Biosystems Launches MammoPort Specimen Containment and Transport System
Technology | Breast Biopsy Systems | October 03, 2018
Leica Biosystems announced the U.S. launch of MammoPort, the first integrated specimen containment and transport system...